IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK [3]

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 1, 2002, Pages 217-218

  Tysall, Luke ^a   Stockdale, Mark W ^a   Chadwick, Paul R ^b   Palepou, Marie France I ^a   Towner, Kevin J ^c   Livermore, David M ^a   Woodford, Neil ^b  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CARBAPENEMASE; IMIPENEM; MEROPENEM; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE REPORT; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; UNITED KINGDOM;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; HUMANS; IMIPENEM; MALE; MIDDLE AGED; THIENAMYCINS;

EID: 0036156692     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Building communication networks: International network for the study and prevention of emerging antimicrobial resistance
2. Acinetobacter species identification by using tRNA spacer fingerprinting
3. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features
4. Carbapenemases: A problem in waiting?
5. Integrons and gene cassettes: A genetic construction kit for bacteria
6. IMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes